Mauro Delorenzi
Mauro Delorenzi
SIB Swiss Institute of Bioinformatics
Verified email at unil.ch
TitleCited byYear
Effects of KRAS, BRAF, NRAS, and PIK3CA mutations on the efficacy of cetuximab plus chemotherapy in chemotherapy-refractory metastatic colorectal cancer: a retrospective …
W De Roock, B Claes, D Bernasconi, J De Schutter, B Biesmans, ...
The lancet oncology 11 (8), 753-762, 2010
19642010
Gene expression profiling in breast cancer: understanding the molecular basis of histologic grade to improve prognosis
C Sotiriou, P Wirapati, S Loi, A Harris, S Fox, J Smeds, H Nordgren, ...
Journal of the National Cancer Institute 98 (4), 262-272, 2006
17872006
The consensus molecular subtypes of colorectal cancer
J Guinney, R Dienstmann, X Wang, A De Reyničs, A Schlicker, ...
Nature medicine 21 (11), 1350-1356, 2015
15592015
Validation and clinical utility of a 70-gene prognostic signature for women with node-negative breast cancer
M Buyse, S Loi, L Van't Veer, G Viale, M Delorenzi, AM Glas, ...
Journal of the National Cancer Institute 98 (17), 1183-1192, 2006
13022006
Prognostic Role of KRAS and BRAF in Stage II and III Resected Colon Cancer: Results of the Translational Study on the PETACC-3, EORTC 40993, SAKK 60-00 …
AD Roth, S Tejpar, M Delorenzi, P Yan, R Fiocca, D Klingbiel, D Dietrich, ...
Journal of clinical oncology 28 (3), 466-474, 2010
9962010
Strong time dependence of the 76-gene prognostic signature for node-negative breast cancer patients in the TRANSBIG multicenter independent validation series
C Desmedt, F Piette, S Loi, Y Wang, F Lallemand, B Haibe-Kains, G Viale, ...
Clinical cancer research 13 (11), 3207-3214, 2007
9392007
Meta-analysis of gene expression profiles in breast cancer: toward a unified understanding of breast cancer subtyping and prognosis signatures
P Wirapati, C Sotiriou, S Kunkel, P Farmer, S Pradervand, B Haibe-Kains, ...
Breast Cancer Research 10 (4), R65, 2008
8192008
Definition of clinically distinct molecular subtypes in estrogen receptor-positive breast carcinomas through genomic grade
S Loi, B Haibe-Kains, C Desmedt, F Lallemand, AM Tutt, C Gillet, P Ellis, ...
Journal of clinical oncology 25 (10), 1239, 2007
8032007
70-gene signature as an aid to treatment decisions in early-stage breast cancer
F Cardoso, LJ van’t Veer, J Bogaerts, L Slaets, G Viale, S Delaloge, ...
New England Journal of Medicine 375 (8), 717-729, 2016
7842016
Identification of molecular apocrine breast tumours by microarray analysis
P Farmer, H Bonnefoi, V Becette, M Tubiana-Hulin, P Fumoleau, ...
Breast Cancer Research 7 (2), P2. 11, 2005
7522005
Biological processes associated with breast cancer clinical outcome depend on the molecular subtypes
C Desmedt, B Haibe-Kains, P Wirapati, M Buyse, D Larsimont, ...
Clinical cancer research 14 (16), 5158-5165, 2008
7392008
A comparison of methods for differential expression analysis of RNA-seq data
C Soneson, M Delorenzi
BMC bioinformatics 14 (1), 91, 2013
7382013
Regional and cellular gene expression changes in human Huntington's disease brain
A Hodges, AD Strand, AK Aragaki, A Kuhn, T Sengstag, G Hughes, ...
Human molecular genetics 15 (6), 965-977, 2006
6572006
The MicroArray Quality Control (MAQC)-II study of common practices for the development and validation of microarray-based predictive models
L Shi, G Campbell, WD Jones, F Campagne, Z Wen, SJ Walker, Z Su, ...
Nature biotechnology 28 (8), 827, 2010
6212010
Stem cell-related" self-renewal" signature and high epidermal growth factor receptor expression associated with resistance to concomitant chemoradiotherapy in glioblastoma
A Murat, E Migliavacca, T Gorlia, WL Lambiv, T Shay, MF Hamou, ...
Journal of clinical oncology 26 (18), 3015-24, 2008
6152008
A stroma-related gene signature predicts resistance to neoadjuvant chemotherapy in breast cancer
P Farmer, H Bonnefoi, P Anderle, D Cameron, P Wirapati, V Becette, ...
Nature medicine 15 (1), 68, 2009
5532009
Cancer cell–autonomous contribution of type I interferon signaling to the efficacy of chemotherapy
A Sistigu, T Yamazaki, E Vacchelli, K Chaba, DP Enot, J Adam, I Vitale, ...
Nature medicine 20 (11), 1301, 2014
4532014
An HMM model for coiled-coil domains and a comparison with PSSM-based predictions
M Delorenzi, T Speed
Bioinformatics 18 (4), 617-625, 2002
3882002
Predicting prognosis using molecular profiling in estrogen receptor-positive breast cancer treated with tamoxifen
S Loi, B Haibe-Kains, C Desmedt, P Wirapati, F Lallemand, AM Tutt, ...
BMC genomics 9 (1), 239, 2008
3532008
Mutant huntingtin's effects on striatal gene expression in mice recapitulate changes observed in human Huntington's disease brain and do not differ with mutant huntingtin …
A Kuhn, DR Goldstein, A Hodges, AD Strand, T Sengstag, C Kooperberg, ...
Human molecular genetics 16 (15), 1845-1861, 2007
3282007
The system can't perform the operation now. Try again later.
Articles 1–20